The Characterization Company for Cell & Gene Therapy

KROMATID is not simply an IND testing company.

KROMATID is the characterization company for cell and gene therapy.

Cell and gene therapies are fundamentally different from traditional medicines because the product is the cell. Understanding that product requires more than knowing whether an intended edit occurred or whether a population passes a regulatory test at the end of development.

Developers need to understand:

• What is the genomic state of the starting material?
• What changes occur during editing?
• Which cells carry those changes?
• Are structural variants emerging?
• Where did transgenes integrate?
• How are genomic abnormalities distributed across the population?
• Does the genomic profile change as the cells are expanded, selected, differentiated, or manufactured?
• Are observed abnormalities treatment-related, process-related, or already present?
• How does the final product compare with its starting material and previous development stages?

Characterization answers these questions.

KROMATID provides high-confidence, single-cell genomic characterization across the cell and gene therapy development lifecycle - giving developers the ability to understand their cells before, during, and after development.

Our role is not simply to test the product.

Our role is to help developers understand the product.